Author/Creator: Bays, Harold E. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Bays, Harold E.

1. Alirocumab Treatment and Achievement of Non‐High‐Density Lipoprotein Cholesterol and Apolipoprotein B Goals in Patients With Hypercholesterolemia: Pooled Results From 10 Phase 3 ODYSSEY Trials. Issue 8 (August 2017)

Authors:: Bays, Harold E.; Leiter, Lawrence A.; Colhoun, Helen M.; Thompson, Desmond; Bessac, Laurence; Pordy, Robert; Toth, Peter P.
Journal:: Journal of the American Heart Association
Issue:: Volume 6:Issue 8(2017)
Page Start:: n/a
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Alirocumab Treatment and Achievement of Non‐High‐Density Lipoprotein Cholesterol and Apolipoprotein B Goals in Patients With Hypercholesterolemia: Pooled Results From 10 Phase 3 ODYSSEY Trials. Issue 8 (8th August 2017)

Authors:: Bays, Harold E.; Leiter, Lawrence A.; Colhoun, Helen M.; Thompson, Desmond; Bessac, Laurence; Pordy, Robert; Toth, Peter P.
Journal:: Journal of the American Heart Association
Issue:: Volume 6:Issue 8(2017)
Page Start:: n/a
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials. Issue 5 (3rd February 2022)

Authors:: Leiter, Lawrence A.; Banach, Maciej; Catapano, Alberico L.; Duell, P. Barton; Gotto, Antonio M.; Laufs, Ulrich; Mancini, G. B. John; Ray, Kausik K.; Hanselman, Jeffrey C.; Ye, Zhan; Bays, Harold E.
Journal:: Diabetes, obesity & metabolism
Issue:: Volume 24:Issue 5(2022)
Page Start:: 868
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Canagliflozin: Effects in overweight and obese subjects without diabetes mellitus. (9th December 2013)

Authors:: Bays, Harold E.; Weinstein, Richard; Law, Gordon; Canovatchel, William
Journal:: Obesity
Issue:: Volume 22:Number 4(2014:Apr.)
Page Start:: 1042
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Characteristics of Patients in the 10th and 90th Percentile of LDL-C Reductions with Alirocumab: ODYSSEY Pooled Analyses. (June 2018)

Authors:: Rosenson, Robert S.; Roth, Eli M.; Ray, Kausik K.; Hovingh, G Kees; Bays, Harold E.; Laufs, Ulrich; Rader, Daniel J.; Baccara-Dinet, Marie T.; Thompson, Desmond; Louie, Michael J.; Leiter, Lawrence A.
Journal:: Atherosclerosis
Issue:: Volume 32(2018)
Page Start:: 12
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Colesevelam, Ezetimibe, and Patients With Type 2 Diabetes Mellitus: Characteristics and Clinical Outcomes From a Health Care Database. (July 2014)

Authors:: Swindle, Jason P.; Ye, Xin; Mallick, Rajiv; Song, Rui; Horstman, Thomas; Bays, Harold E.
Journal:: Annals of pharmacotherapy
Issue:: Volume 48:Number 7(2014:Jul.)
Page Start:: 847
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Effect of alirocumab dose increase on LDL lowering and lipid goal attainment in patients with dyslipidemia. Issue 3 (May 2017)

Authors:: Kastelein, John J.P.; Kereiakes, Dean J.; Cannon, Christopher P.; Bays, Harold E.; Minini, Pascal; Lee, L. Veronica; Maroni, Jaman; Farnier, Michel
Journal:: Coronary artery disease
Issue:: Volume 28:Issue 3(2017:May)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Efficacy and Safety of Alirocumab as Add‐on Therapy in High–Cardiovascular‐Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosuvastatin (10 or 20 mg): Design and Rationale of the ODYSSEY OPTIONS Studies. Issue 10 (30th September 2014)

Authors:: Robinson, Jennifer G.; Colhoun, Helen M.; Bays, Harold E.; Jones, Peter H.; Du, Yunling; Hanotin, Corinne; Donahue, Stephen
Journal:: Clinical cardiology
Issue:: Volume 37:Issue 10(2014:Oct.)
Page Start:: 597
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Fingerstick Precision and Total Error of a Point-of-Care HbA1c Test. (September 2020)

Authors:: Arnold, William D.; Kupfer, Kenneth; Hvidsten Swensen, Monica; Fortner, Kyle S.; Bays, Harold E.; Davis, Mathew; Klaff, Leslie J.; San George, Richard C.
Journal:: Journal of diabetes science and technology
Issue:: Volume 14:Number 5(2020:Sep.)
Page Start:: 890
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. Fixed‐dose combination ezetimibe+atorvastatin lowers LDL‐C equivalent to co‐administered components in randomized trials: use of a dose–response model. (27th February 2015)

Authors:: Bays, Harold E.; Chen, Erluo; Tomassini, Joanne E.; McPeters, Gail; Polis, Adam B.; Triscari, Joseph
Journal:: Fundamental & clinical pharmacology
Issue:: Volume 29:Number 2(2015)
Page Start:: 209
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗